Florida International University

FIU Digital Commons
Department of Dietetics and Nutrition

Robert Stempel College of Public Health & Social
Work

4-23-2013

Obesity Indicators by Race/Ethnicity for Diagnosis
of Cardiometabolic Diseases for a US
Representative Sample of Adults
Joan A. Vaccaro
Department of Dietetics and Nutrition, Florida International University, jvaccaro@fiu.edu

Fatma G. Huffman
Department of Dietetics and Nutrition, Florida International University, huffmanf@fiu.edu

Follow this and additional works at: https://digitalcommons.fiu.edu/dietetics_nutrition_fac
Part of the Dietetics and Clinical Nutrition Commons
Recommended Citation
Vaccaro, Joan A. and Huffman, Fatma G., "Obesity Indicators by Race/Ethnicity for Diagnosis of Cardiometabolic Diseases for a US
Representative Sample of Adults" (2013). Department of Dietetics and Nutrition. 6.
https://digitalcommons.fiu.edu/dietetics_nutrition_fac/6

This work is brought to you for free and open access by the Robert Stempel College of Public Health & Social Work at FIU Digital Commons. It has
been accepted for inclusion in Department of Dietetics and Nutrition by an authorized administrator of FIU Digital Commons. For more information,
please contact dcc@fiu.edu.

Cardiovascular System
ISSN 2052-4358

Research							

Open Access

Obesity indicators by race/ethnicity for diagnosis of
cardiometabolic diseases for a US representative sample
of adults
Joan A. Vaccaro1* and Fatma G. Huffman1
*Correspondence: jvaccaro@fiu.edu
1
Florida International University, Robert R. Stempel College of Public Health and Social Work, Department of Dietetics and Nutrition,
Miami, Florida, USA.

Abstract

Background: Obesity, a growing epidemic, is a preventable risk factor for cardiometabolic diseases. Obesity and cardiometabolic
diseases affect Hispanics and African Americans more than non-Hispanic Caucasians. This study examined the relationship
among race/ethnicity, obesity diagnostic measures (body mass index, waist circumference, subscapular and triceps skinfold
thickness), and cardiometabolic risk factors (hyperglycemia, high, non-high-density lipoprotein cholesterol, low, high-density
lipoprotein cholesterol, and hypertension) for adults across the United States.
Methods: Using data from two-cycles of the National Health and Examination Survey (NHANES) 2007-2010, and accounting
for the complex sample design, logistic regression models were conducted comparing obesity indicators in Mexican Americans,
other Hispanics, and Black non-Hispanics, with White non-Hispanics and their associations with the presence of cardiometabolic
diseases.
Results: Differences by race/ethnicity were found for subscapular skinfold thickness and hyperglycemia. Waist circumference and
subscapular skinfold were positively associated with the presence of hyperglycemia; dyslipidemia, and hypertension across race/
ethnicity, adjusting for age, gender, smoking, physical activity, education, income to poverty index, and health insurance. Race/
ethnicity did not influence the association of any obesity indicators with the tested cardiometabolic diseases. All obesity measures
except triceps skinfold were associated with hyperglycemia.
Conclusions: We suggest that subscapular skinfold thickness be considered as an inexpensive non-intrusive screening tool for
cardiometabolic risk factors in an adult US population.
Keywords: Cardiovascular diseases, diabetes, hyperglycemia, hypertension, dyslipidemia, obesity, skinfold measures, race/ethnicity

Introduction

Obesity, 20% or more over ideal body weight, is a growing
epidemic across race/ethnicity in the United States. From
1960-2006, the percentage of obese adults more than doubled,
increasing from 13% to 35% [1]. Although there was not
an increase in obesity from 2007 to 2010 [2,3], there are
subpopulations whose rates exceeded the average. The
prevalence of obesity is higher in African Americans (1.4) and
Hispanics (1.2) as compared to non-Hispanic Whites [4]. Obesity
has been clinically defined by several measures, including
waist circumference and body mass index (BMI). Individuals
whose body mass index (BMI) ≥ 30 kg/m2 are considered obese
[3,5]. Based on a recent systematic meta-analysis of US and
international populations, obese individuals were significantly
were associated with higher mortality as compared to normal
weight individuals [6]. (Flegal et al., 2013). Cardiometabolic risk
is considered with waist circumference ≥102 cm (≥40 in) for
men and ≥88 cm (≥35 in) for women; however, there is evidence
that these cutoffs may be lower in certain races/ethnicities [7].
Truncal skinfold thickness and waist circumference measures
are considered indicators of central obesity. Skinfold thickness
has been associated with body fatness and may be a better
indicator of adverse health outcomes than BMI [8].

Obesity is among the major risk factors of cardiometabolic
diseases including hyperglycemia (prediabetes/diabetes),
hypertension and dyslipidemia [9]. Over one-quarter of a
million premature deaths in the US per year are attributed to
obesity [10]. The incidence of heart diseases, including diabetes,
hypertension, and dyslipidemia, is greater for persons who are
obese [10]. Early diagnosis and treatment depends on access
to healthcare and uninsured persons are less-likely to receive
medical care [11]. A higher percent of African Americans (20.8)
and Hispanics (30.7) have no health insurance as compared to
non-Hispanic Whites (11.7) [4]. Obesity screening methods for
hard to reach population have not been determined. Health
fairs and community health screenings with subscapular and
triceps skinfold measurement may be more effective than taking
weight, height and waist circumference. The purpose of this
study is to assess the association of these obesity indicators
with cardiometabolic diseases: hyperglycemia, hypertension,
and high, non-high-density lipoprotein cholesterol (non-HDL-C),
and low, high-density lipoprotein cholesterol (HDL-C).

Materials and methods
Source of data

Data for this study were from appended 2-year cycles of datasets
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from the National Health and Nutrition Examination Survey
(NHANES) 2007-2008 and 2009-2010 [12]. NHANES uses a
complex, multistage, probability sample design to obtain
representative samples of the noninstitutionalized, civilian
US population [12]. This study acquired data (N=11,377) for
males and females ≥ 21 years of aged from four out of five
racial/ethnic categories: Mexican Americans (MA); Other
Hispanics (OH); Black non-Hispanics (BNH); and White nonHispanics (WNH). The classification ‘other races’ (Asian and
mixed-races) was excluded since numbers in this category
were not sufficient for multiple comparisons. The final sample
size with data for the study variables was N=8850 (MA=1654,
OH=1010, BNH=1591, WNH=4595).

doi: 10.7243/2052-4358-1-4
adding variables for high non-HDL-C, high triglycerides (≥150
mg/dL), and low, HDL (<40 mg/dL for men and <50 mg/dL for
women). A score of ≥ 1 was considered having dyslipidemia.
Hypertension was computed as a binary variable where
systolic blood pressure ≥ 140 mmHg or diastolic blood
pressure ≥ 90 mmHg.

Adjustment variables

Clinically significant covariates and potential confounders
were tested with Pearson’s and Spearmen Rho’s correlations.
All variables were retained for full models except marital
status. Categories for education were collapsed to three: <
high school, high school, > high school to assure sufficient
power based on the estimated marginal means. A variable
Ethical considerations
for physical activity: moderate or vigorous physical activity
The data used for this study were publically available. Prior to was computed by adding the yes and no responses for each
public release, the study protocols (continuation of protocol category, then forming a binary variable for engaging in
#2005-06 for both datasets) were approved by the National either moderate or vigorous physical activity. The income to
Center for Health Statistics Research Ethics Review Board poverty index was used to adjust for income. Health insurance
(NCHS-ERB) [13]. Separate informed consent forms were signed was measured as a binary variable (yes/no). Smoking status
by participants for the interview and health examination, or was collapse to a binary variable, currently smoking (yes/no).
just the interview. Participants for this study read, understood, In addition, variables for, gender (binary) and age in years
and signed informed consent forms for the interview and (continuous) were used from the dataset.
health examination.

Major variables

Independent variables included race/ethnicity and obesity
indicators. A nominal category for race/ethnicity recoded
for WNH as the reference. The category “other races” was
eliminated with a filter. Waist circumference was tested
for linearity and used as a continuous variable. Body mass
index (BMI) was coded as an ordinal variable with four levels
combining the World Health Organization (WHO)’s categories
[5] as follows: underweight and normal were collapsed to
category 1 (BMI < 25 kg/m2); category 2 corresponded to pre
obese (BMI = 25-29.9 kg/m2); category 3 corresponded to
obese, class I (BMI = 30-34.9 kg/m2); and, category 4 combined
obese classes II and III (BMI ≥ 35kg/m2 ). Waist circumference
and skinfold thickness measurements, including triceps
and subscapular, were categorized in quartiles. Dependent
variables were prediabetes or diabetes, dyslipidemia, and
hypertension. The variable for hyperglycemia was computed
by % glycated hemoglobin (A1C) ≥ 6.0, dyslipidemia, abnormal
levels of one or more of the lipoproteins, was measured by
low HDL-C and high, non-HDL-C ≥130 mg/dL. Cutoffs for low
HDL-C were <40 mg/dL for men and <50 mg/dL for women
[14]. The variable for non-HDL-C was created by subtracting
HDL-C from total cholesterol, then computing the binary
variable. The American Association of Clinical Endocrinologists
(AACE) recommend non-HDL-C be less than 30mg/dL above
the target for low-density lipoprotein cholesterol (LDL-C <100
mg/dL) [14]. Non-HDL-C is the sum of all lipoproteins except
HDL-C and includes LDL-C intermediate and very low-density
lipoproteins, lipoprotein (a). A dyslipidemia score was created

Statistical analysis

The general characteristics of the study population by race/
ethnicity were determined using complex sample design
logistic regression models for categorical variables and
general linear models for continuous variables with WNH
as the reference group. Reduced and full logistic regression
models were performed for each cardiometabolic risk factor.
Reduced models included 1- and 2-way interactions of race/
ethnicity with each obesity indicator and were adjusted by
age and gender. When no interaction was present, the 2-way
term was dropped to achieve optimal model fit. Full models
included the covariates of the reduced models along with
currently smoking, education, health insurance, income
to poverty index, and physical activity. Adjusted sample
weights were used to account for unequal probabilities
of selection and nonresponse in the multistage stratified
cluster sampling design used in NHANES to achieve unbiased
national estimates. The sample weights used were based on
the Mobile Examination Center (MEC) and were computed
using the average of the 2-year sample weights for each cycle,
as per guidelines set by NHANES [12,15]. Data analysis was
conducted with the complex sampling module, IBM-SPSS
version 20. The Wald F statistic was used to determine model
significance for logistic regression analysis [16]. A P-value of
<.05 was considered significant.

Results

Risk factors associated with obesity and obesity indicators by
race/ethnicity are depicted in (Table 1). Compared to WNH,
other racial/ethnic groups were younger, had lower incomes,

2

Vaccaro et al. Cardiovascular System 2013,
http://www.hoajonline.com/journals/pdf/2052-4358-1-4.pdf

doi: 10.7243/2052-4358-1-4

Table 1. Major cardiometabolic risk factors of the study population by race/ethnicity.
Variable

MA

OH

BNH

WNH reference

P-value

Continuous variables –mean (SE)
Age (years)

40.9(0.65)**

42.2(0.71)**

45.0(0.59)**

49.2(0.37)

<.001

Income to poverty index

1.84(0.05)**

2.07(0.07)**

2.34(0.08)**

3.32(0.07)

<.001

Glycated hemoglobin (%)

5.71(0.04)*

5.65(0.04)

5.84(0.03)**

5.56(0.02)

<.001

Waist circumference (cm)

98.9(0.54)

96.7(0.68)*

99.7(0.53)

98.7(0.37)

.016

Male (cm)

100.2(0.81)*

99.4(.94)*

98.3(0.62)*

102.5(0.42)

<.001

Female (cm)

97.5(0.47)*

94.2(0.76)

100.9(0.70)**

95.1(0.49)

<.001

19.0(0.34)

19.4(0.38)

20.5(0.29)*

19.3(0.20)

.003

22.5(0.31)**

22.3(0.34)**

23.3(0.36)**

20.5(0.18)

<.001

Triceps skinfold thickness (mm)
Subscapular skinfold thickness (mm)
Categorical variables –percent within race/ethnicity (SE)
Triceps (75th % >25.5 mm)

23.2(1.2)

24.8(1.7)

33.2(1.1)*

23.8(1.0)

<.001

Subscapular (75th % >27.4 mm)

26.4(1.6)**

26.1(2.1)**

35.9(1.6)**

21.7(0.9)

<.001

Body mass index (BMI ≥ 35 kg/m2)

18.3(0.9)**

17.3(1.4)

26.1(1.2) **

16.4(1.6)

<.001

Diabetes (A1C ≥6.5%)

10.1(1.0)**

8.4(0.8)**

12.3(0.7)**

6.8(0.6)

<.001

Hyperglycemia (A1C ≥6.0%)

18.4(1.2)*

16.9(1.3)

26.6(1.3)**

14.8(1.0)

<.001

High non-HDL-cholesterol (≥130mg/dL)

33.6(1.3)*

36.4(1.8)

45.7(1.3)**

37.0(0.7)

<.001
<.001

Hypertension (yes)

19.8(1.5)**

21.6(1.6)**

39.5(1.3)**

32.3(1.0)

Currently smoking (yes)

22.5(1.2)**

14.8(1.8)

21.6(1.7)

19.1(1.2)

.001

No health insurance

51.4(1.8)**

36.0(3.1)**

25.7(1.4)**

13.4(0.7)

<.001

Education <high school

51.9(1.6)**

37.6(2.4)**

26.1(1.8)**

13.7(1.4)

<.001

Engage in moderate or vigorous physical activity (yes)

39.3(2.1)**

41.3(1.7)**

41.8(1.2)**

54.7(2.3)

<.001

High sedentary activity >4 hours/day

44.3(2.5) **

51.7(2.1)**

*65.9(1.8)

72.8(1.2)

<.001

Abbreviations: MA: Mexican American; OH: other Hispanic; BNH: Black non-Hispanic; WNH: White non-Hispanic; A1C:
glycated hemoglobin (hemoglobin A1c).
Notes: Continuous variables were reported as weighted means (SE). Categorical variables were reported as population percent
(SE). P-values test the differences by race/ethnicity by the Wald F-statistic; asterisk symbols denote significant differences of
each race/ethnicity as compared to White non-Hispanics (WNH). Income to poverty index is based on a scale (0-5) where 0-1 is
below poverty, 1.0 is at poverty and other values measure relative distance from poverty. Non-HDL-cholesterol=non-high-density
lipoprotein cholesterol. Pulse pressure was measured as the difference between the average systolic blood pressure and average
diastolic blood pressure.
* = P<.05; ** = P<.001.

less education and a higher prevalence of not having health hypertension. BMI was associated with Model 1 (hyperglycemia),
insurance. WNH had a higher prevalence of engaging in only. Triceps skinfold thickness was not a significant indicator
moderate or vigorous physical activity, but spent more hours for the diseases tested. For (Model 1), subscapular skinfold
of sedentary activity as compared to other ethnic/racial groups. thickness at the lowest quartile was 2.63 times less likely
Obesity indicators had different patterns by race/ethnicity; to have high A1C as compared to the highest quartile. The
however, subscapular skinfold thickness was significantly Odds Ratio for the lowest quartile subscapular skinfold
higher for all groups as compared to WHN. Diabetes and thickness (0.38) represents the decrease in likelihood for high
hypertension were more prevalent in all groups as compared A1C as compared to the Odds Ratio of 1.00 for the highest
to WNH. High A1C (prediabetes and diabetes) was more quartile) (Model 1). Waist circumference had a stronger
prevalent in MA and BNH as compared to WNH. The percent association with high A1C than subscapular skinfold thickness
of high non-HDL cholesterol was greater for MA and BNH as (Model 1). The lowest quartile was 4.00 times less likely than
compared to WHN. The fully adjusted models maintained the the highest quartile to have high A1C (prediabetes or diabetes)
same patterns as the reduced models.
(Model 1). BMI and triceps skinfold thickness were not
Final reduced and fully adjusted logistic regression analyses significantly associated with high A1C (Model 1). Model 2
(Models 1,2,3) for the effect of obesity indicator and race on (reduced and fully adjusted), depicts those in the lowest
cardiometabolic disease states are shown in (Table 2). There quartiles of waist circumference and subscapular skinfold
were differences by race for all cardiometabolic diseases thickness were more likely to have high non HDL-C than
tested; however, two-way interactions of race/ethnicity by those in the highest quartiles (see Table 2 legend notes). Since
each of the obesity indicators were not significant. Therefore, hypertension and hyperglycemia are commonly associated
interactions are not presented in the final models. For each with dyslipidemia, additional analyses were conducted.
model, subscapular skinfold and waist circumference measures (Table 3) presents the final models with Odds Ratios of race/
were significant obesity indicators associated with each ethnicity and obesity indicators for two models of dyslipidemia,
cardiometabolic disease: hyperglycemia, dyslipidemia, and Model A, non-HDL-C and Model B, HDL-C. Both the reduced
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Table 2. Likelihood for cardiometabolic diseases by race/ethnicity and obesity indicators.
Dependent variables (disease state)
Model 1. A1C ≥6.0
(Hyperglycemia)

Model 2. Non-HDL-C ≥130 mg/dL
(Dyslipidemia)

Independent variables (risk factors)

Reduced Models OR (95% CI)

Race/ethnicity

P<.001

Full Models OR (95% CI)
P<.001

MA

2.58(1.94, 3.44)

1.94(1.39, 2.72)

OH

2.17(1.51, 3.12)

1.72(1.12, 2.66)

BNH

3.06(2.36, 3.99)

2.57(1.94, 3.41)

WNH (reference)

1.00

1.00

Subscapular skinfold thickness

P<.001

P<.001

25th percentile

0.38(0.29, 0.52)

0.34(0.26, 0.45)

50th percentile

0.49(0.39, 0.60)

0.47(0.38,0.58)

75th percentile

0.72(0.57, 0.92)

0.68(0.51, 0.90)

>75th percentile (reference)

1.00

1.00

Triceps skinfold thickness

ns (P=.195)

ns (P=.460)

BMI

(P=.041)

(P=.020)

< 25 kg/m2

0.61(0.40, 0.94)

0.56(0.36, 0.87)

25-29.9 kg/m2

0.60(0.43, 0.84)

0.57(0.41, 0.79)
0.74(0.54, 1.03)

30-34.9 kg/m2

0.74(0.55, 1.00)

≥ 35 kg/m2 (reference)

1.00

1.00

Waist circumference

P<.001

P<.001
0.28(0.19, 0.43)

25th percentile

0.25(0.16, 0.38)

50th percentile

0.52(0.39, 0.68)

0.57(0.42, 0.76)

75th percentile

0.64(0.50, 0.82)

0.68( 0.51, 0.90)

>75th percentile (reference)

1.00

1.00

Race/ethnicity

P<.001

P<.001

MA

0.90(0.78, 1.02)

0.92(0.78, 1.08)

OH

1.02(0.83, 1.26)

1.03(0.83, 1.27)

BNH

1.57(1.34, 1.84)

1.59(1.34, 1.88)

WNH (reference)

1.00

1.00

Subscapular skinfold thickness

P<.001

P<.001

25th percentile

1.81(1.38, 2.37)

1.80(1.37, 2.38)

50th percentile

1.21(0.94, 1.55)

1.20(0.93, 1.56)
1.59(1.34, 1.88)

75th percent

0.94(0.80, 1.12)

>75th percent (reference)

1.00

1.00

Triceps skinfold thickness

ns (P=.432)

ns (P=.456)

BMI (kg/m2)

ns P=.074

ns P=.062

Waist circumference

P<.001

P<.001

25th percentile

1.55(1.12, 2.13)

1.51(1.09, 2.10)

50th percentile

0.84(0.61, 1.15)

0.83(0.61, 1.14)

75th percentile

0.77(0.63, 0.95)

0.76(0.62, 0.94)

>75th percentile (reference)

1.00

1.00

MA: Mexican American; OH: other Hispanic; BNH: Black non-Hispanic; WNH: White non-Hispanic; A1C: glycated
hemoglobin (hemoglobin A1c); BMI: body mass index.
Notes: Reduced models included race/ethnicity and obesity indicators, and were adjusted for age and gender; full
models included variables in the reduce model with additional adjustments for smoking, health insurance, education,
income to poverty index, and physical activity. Model 2 suggests possible confounders, such as cholesterol-lowing
medications, and individual variation may have influenced the relationship of level of obesity and presents of high
non-HDL-C. Cholesterol medication variables were available not for the entire sample. A model was run with this
limited sample (n=2317). The adjustment did not change the direction of obesity indicators; the lowest quartiles of
obesity indicator were still associated with an increased likelihood of high non-HDL-C.

models and fully adjusted models include two measures each obesity indicator were not significant for both models.
of cardiometabolic diseases associated with dyslipidemia, Therefore, interactions are not presented in the final models.
hyperglycemia and hypertension. There were significant Models with dyslipidemia measured as having at least one of
differences by race/ethnicity for these dyslipidemia indicators; the following: high non-HDL-C, low HDL-C, or high triglycerides
however, the two-way interactions for race/ethnicity by did not achieve adequate fit and classification. This may
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Table 2 (continued). Likelihood for cardiometabolic diseases by race/ethnicity and obesity indicators.
Dependent variables (disease state)

Independent variables (risk factors)

Reduced Models OR (95% CI)

Full Models OR (95% CI)

Model 3. SBP ≥140 or DBP ≥ 90

Race/ethnicity

P<.001

P<.001

mmHg (Hypertension )

MA

0.86(0.70, 1.04)

0.81(0.65, 1.01)

OH

0.84(0.69, 1.01)

0.80(0.64, 0.99

BNH

2.14, 1.73, 2.64)

2.03(1.66, 1.48)

WNH (reference)

1.00

1.00

Subscapular skinfold thickness

P=.001

P=.001

25th percentile

0.64(0.52, 0.80)

0.64(0.51, 0.80)

50th percentile

0.78(0.64, 0.95)

0.78(0.64, 0.94)

75th percentile

0.97(0.79, 1.18)

0.96(0.79, 1.17)

>75th percent (reference)

1.00

1.00

Triceps skinfold thickness

ns P=.264

ns P=.338

BMI

ns P=.074

ns P=.062

Waist circumference

P <.001

P<.001

25th percentile

0.42(0.30, 0.59)

0.44(0.32, 0.61)

50th percentile

0.62(0.43, 0.88)

0.64(046, 0.90)

75th percentile

0.81(0.59, 1.11)

0.83(0.61, 1.12)

>75th percentile (reference)

1.00

1.00

MA: Mexican American; OH: other Hispanic; BNH: Black non-Hispanic; WNH: White non-Hispanic; A1C: glycated
hemoglobin (hemoglobin A1c.); BMI: body mass index.
Notes: Reduced models included race/ethnicity and obesity indicators, and were adjusted for age and gender; full
models included variables in the reduce model with additional adjustments for smoking, health insurance, education,
income to poverty index, and physical activity.

be due, in part, to the high percent of missing values for
triglycerides. In addition, separate model were run for men
and women for each measure of dyslipidemia; however, the
patterns of significance were the same as for the combined
model (data not shown).
Separate models of dyslipidemia measures (Models A and
B) were conducted (Table 3). For Model A, individuals with
hyperglycemia were more likely to have high non-HDL-C in
both the reduced [OR=1.57(1.34, 1.83)] and the fully adjusted
[OR= 1.60(1.37, 1.88] models. The Odds Ratios for high nonHDL-C for persons with hypertension were greater than for
people without hypertension in the reduced [1.25(1.06, 1.47)]
and fully adjusted [1.24(1.06, 1.46)] models. BNH had a higher
Odds Ratio of high non-HDL-C as compared to WNH in the
reduced [1.45(1.24, 1.71)] and fully adjusted [1.49(1.25, 1.76)]
models. Individuals in the lowest quartile of subscapular
skinfold thickness were more likely to have high non-HDL-C
as compared to those in the highest quartile in the reduced
[OR=1.89(1.45, 2.47)] and fully adjusted [OR= 1.90(1.44, 2.49)]
models. This unexpected, inverse relationship was found for
waist circumference, as well, where the 1st quartile was more
likely to have high non-HDL-C as compared to the 4th quartile
for the reduced [OR=1.70(1.22, 2.36)] and fully adjusted
[OR= 1.65(1.19, 2.30)] models. For Model B, low HDL-C,
individuals with hyperglycemia were more likely to have
low HDL-C in both the reduced [OR= 1.98(1.62, 1.78)] and
fully adjusted [OR=1.78(1.47, 2.16)] models as compared to
those with normal A1C. Low HDL-C was more likely for those
with as compared to without hypertension for the reduced
[OR=1.23(1.05, 1.45)] and fully adjusted [OR=1.21(1.03, 1.43)]
models. BNH were less-likely to have low HDL-C as compared

to WHN in the reduced [OR=0.53(0.42, 0.66)] and fully adjusted
[OR=0.43(0.34, 0.55)] models. Individuals of normal BMI’s were
significantly less likely to have low HDL-C than those with
BMI’s ≥35 kg/m2. Persons with waist circumference in the
25th and 50th percentiles were less likely to have low HDL-C
as compared to the highest quartile (> 75th). Triceps skinfold
thickness was not significant for any model and BMI was only
significant in the fully adjusted model for HDL-C.

Discussion

Subscapular skinfold thickness and waist circumference were
both significantly associated with hyperglycemia, dyslipidemia,
and hypertension, independent of race/ethnicity. BMI was
related to hyperglycemia, only. Triceps skinfold thickness
was not associated with any of the cardiometabolic diseases.
Adults in the under- and normal-weight categories were more
likely to have high non-HDL-C. The findings suggest that
obesity indicators may be an ineffective method of screening
for dyslipidemia in normal weight adults.
Additionally, our findings reconfirm racial/ethnic health
disparities are still prevalent in the US. We found BNH to have
the highest odds of having prediabetes/diabetes, dyslipidemia,
and hypertension, as compared to WNH adjusting for obesity
and sociodemographics. All groups (MA, OH, and BNH)
had higher odds of prediabetes/diabetes as compared to
WNH, adjusting for obesity and sociodemographics. Our
results suggests measures of central obesity, such as waist
circumference and subscapular skinfold measurements, are
better indicators of cardiometabolic diseases than BMI or
peripheral obesity (measured by triceps skinfold thickness)
for a representative national sample of US adults across race/
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Table 3. Effect of obesity indicators with hyperglycemia and hypertension on dyslipidemia.
Models A and B
Independent variables

A. Dependent variable: high, non-HDL-C

B. Dependent variable: low, HDL-C

Reduced Model OR (95% CI)

Full Model OR (95% CI)

Reduced Model OR (95% CI)

Full Model OR (95% CI)

Hyperglycemia

1.57(1.34, 1.83)

1.60(1.37, 1.88)

1.98(1.62, 2.42)

1.78(1.47, 2.16)

Hypertension

1.25(1.06, 1.47)

1.24(1.06, 1.46)

1.23(1.05, 1.45)

1.21(1.03, 1.43)

Race/ethnicity

P <.001

P <.001

P <.001

P <.001

MA

0.86(0.076, 0.99)

0.91(0.78, 1.07)

1.13 (0.88, 2.46)

0.93(0.70, 1.23)

OH

0.99(0.79, 1.23)

1.00(0.81, 1.25)

0.98(0.80, 2.21)

0.81(0.66, 0.99)

BNH

1.45(1.24, 1.71)

1.49(1.25, 1.76)

0.53 (0.42, 0.66)

0.43(0.34, 0.55)

1.00

1.00

1.00

1.00

P <.001

P <.001

P <.001

P <.001

25th percentile

1.89(1.45, 2.47)

1.90(1.44, 2.49)

0.48(0.36, 0.63)

0.42(0.32, 0.57)

50 percentile

1.25(0.97, 1.60)

1.25(0.97, 1.61)

0.67(0.56, 0.80)

0.64(0.53, 0.76)

75th percentile

0.96(0.81, 1.13)

0.96(0.81, 1.14)

0.85(0.72, 1.02)

0.82(0.69, 0.98)

1.00

1.00

1.00

1.00

Triceps skinfold thickness

ns P=.244

ns P=.195

ns P=.887

ns P=.529

BMI (kg/m2)

ns P=.377

ns P=.423

ns P=.151

P=.015

-

-

-

0.61(0.44, 0.85)

25-29.9 kg/m2

-

-

-

0.78(0.60, 1.02)

30-34.9 kg/m

-

-

-

0.88(0.67, 1.18)

≥ 35 kg/m2 (reference)

-

-

-

1.00

P <.001

P <.001

P <.001

P <.001

25th percentile

1.70(1.22, 2.36)

1.65(1.19, 2.30)

0.44(0.30, 0.63)

0.54(0.38, 0.76)

50 percentile

0.90(0.66, 1.24)

0.89(0.65, 1.22)

0.62(0.44, 0.88)

0.71(0.52, 0.97)

75th percentile

0.81(0.66, 0.99)

0.80(0.65, 0.99)

0.91(0.70, 1.18)

0.98(0.76, 1.26)

1.00

1.00

1.00

1.00

WNH (reference)
Subscapular skinfold thickness
th

>75th percentile (reference)

< 25 kg/m2
2

Waist circumference
th

>75th percentile (reference)

Abbreviations: MA: Mexican American; OH: other Hispanic; BNH: Black non-Hispanic; WNH: White non-Hispanic; A1C:
glycated hemoglobin (hemoglobin A1c); BMI: body mass index.
Notes: Reduced models included prediabetes/diabetes (A1C ≥6.0), hypertension (SBP ≥140 or DBP ≥ 90 mmHg)
race/ethnicity and obesity indicators, and were adjusted for age and gender; full models included variables in the reduce
model with additional adjustments for smoking, health insurance, education, income to poverty index, and physical activity.

ethnicity. However, caution needs to be exercises when using
obesity indicators screening for dyslipidemia.
The obesity indicator that is most useful in screening adults
for risk of diabetes, hypertension, and dyslipidemia has not
been established. There is no concordance in the literature
for an obesity indicator specific for each racial/ethnic group.
Whether BMI or central obesity measures are more suitable
indicators of CVD risk remains an area of disagreement. In a
combined analysis of four longitudinal studies of Caucasians,
there was no difference in central obesity compared to BMI
in predicting diabetes and heart disease [17]. These results
may not be applicable to Blacks and Hispanics. For example,
MacKay et al., [18] found obesity indicators for African
Americans to differ as compared to Hispanics and WNH using
area under the receiver operating characteristic (AROC) curve
(c-statistic) [18]. While central and overall obesity predicted
the 5-year incidence of diabetes for other racial/ethnic groups,
only central obesity predicted the incidence of diabetes for
African Americans [18]. The investigators found subscapular
to triceps ratio was the most predictive of diabetes for African

Americans; while BMI was most predictive of diabetes for
Hispanics and WNH [18]. Misra et al., [19] reviewed average
values of waist circumference with associated CVD risk and
found differences in optimal cutoff points by race/ethnicity. The
authors attribute these differences to race/ethnic determinants
of abdominal tissue that are influenced by the distribution of
skeletal muscle, body fat, and bone [19]. For a population of
multiracial children, combined CVD risk factors (serum lipids,
fasting insulin, and blood pressure) prevalence was predicted
by both BMI and skinfold sum (triceps and scapular) equally
for the 85-94th percentile; albeit, the investigators noted BMI
had a higher ratio for the comparison of ≥95th versus <25th
percentiles [8]. Schubert et al., [20] reported that for adults, BMI,
without bioelectric impedance correction, does not distinguish
between fat and fat-free mass. In their longitudinal study of
men and women, aged 40-60 years, there were significant
increases in total cholesterol, low-density cholesterol, and
triglycerides as fat-mass increased [20].
Skinfold thickness measurements have also been considered
as an obesity indicator and markers for CVD risk including
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prediabetes and diabetes. In a review of obesity indicators of includes small-dense LDL particles, was not measured; albeit
CVD risk, Snijder et al., [21] considered subscapular skinfold non-HDL-C has been found to correlate more strongly with
thickness to be a promising, simple indicator of central obesity two indicators of atherogenic dyslipidemia, apoprotein (a)
citing several studies that found associations of skinfold and small dense LDL particles [29]. Another limitation of this
thickness with high blood pressure and dyslipidemia. In a study was that cholesterol-lowering medication use was not
cohort of men, incidence of coronary heart disease after a available for the complete sample; however, in an analysis
12 year follow-up was associated with subscapular skinfold of the subsample where medication use was available, the
thickness, independent of BMI and adjusting for confounders pattern of significance was the same with or without this
[22]. Subscapular skinfold thickness, a measure of fat mass, was adjustment. Additionally, family history of high cholesterol
found to be a better predictor of CVD risk in cluster analysis was not available and may have been a confounder with
as compared to BMI for Asian Indian adolescents [23]. Truncal obesity for non-HDL-C but not for HDL-C. The effect of obesity
skinfold thickness (subscapular, iliac and abdominal measures indicators in these dyslipidemia outcomes may be attributed
summed) was the sole predictor of plasma insulin after oral to the fact that statins and other cholesterol medications
glucose tolerance test for adults across BMI categories for seldom achieve improvement in HDL-C [30].
adults with prediabetes and diabetes [24]. The investigators
recommend the use of skinfold thickness measure in screening Conclusions
for abnormal glucose or insulin [24]. Subscapular skinfold Although obesity indicators and cardiometabolic diseases
thickness, as compared to other obesity indicators (BMI, waist differed by race/ethnicity; the effect of obesity indicators
to hip ratio, waist circumference, abdominal measures, and on these diseases were not influenced by race/ethnicity.
other skinfold thickness measurements) was significantly Subscapular skinfold thickness and waist circumference,
higher for those with persistent impaired glucose tolerance measures of central obesity, were positively associated
(prediabetes) [25].
with hyperglycemia, hypertension, and one measure of
Our results indicating that obesity indicators may not be dyslipidemia, low-HDL. Conversely, both subscapular skin fold
suitable for dyslipidemia screening have been supported by thickness and waist circumference had an inverse association
the literature. Low-density lipoprotein cholesterol (LDL-C) with non-HDL-C, suggesting the presence of confounders.
was not significantly associated with subcutaneous fat in BMI was positively associated with hyperglycemia; however,
normal weight Caucasian adults, neither for males nor for relationships with non-HDL-C and HDL-C reduced models
female [26]. The investigators found associations with visceral, were not significant. There was a weak association of BMI and
but not subcutaneous fat related to blood lipids [26]. Kim HDL-C in the fully adjusted model. Triceps skinfold thickness,
et al., [27] found controlling for waist circumference did not a measure of peripheral body fat, was not associated with
influence the positive association between body fat mass and any of the assessed cardiometabolic disease. Subscapular
cardiometabolic risk factors (hyperglycemia and dyslipidemia) skinfold measure should be considered as part of a screening
for Korean adults of normal body weight (measured by BMI for cardiometabolic diseases for adults in the US population.
adjusted for Asian body type). There were no significant
prevalence rates for diabetes, hypertension, and dyslipidemia Competing interests
according to increasing BMI ≥35 kg/m2 for African Americans, The authors declare that they have no competing interests.
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